CHARLES MINARD to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications CHARLES MINARD has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.165
-
Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213). Pediatr Blood Cancer. 2018 05; 65(5):e26944.
Score: 0.103
-
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614). Pediatr Blood Cancer. 2024 Jun; 71(6):e30938.
Score: 0.040
-
Outcomes of two-drug maintenance immunosuppression for pediatric renal transplantation: 10-yr follow-up in a single center. Pediatr Transplant. 2016 Feb; 20(1):49-58.
Score: 0.022